CAG
23
-4
CFG
61
-2
BAX
47
-3
TXN
40
-3
EL
50
2
TSCO
66
-2
EQIX
54
-3
PYPL
29
-4
VFC
47
3
VRSN
49
-4
FDX
47
-4
O
31
-8
EQT
42
3
EQR
44
-7
OMC
51
-4
FMC
41
-3
PH
60
-2
TDC
38
-4
VIX
40
-9
DAL
54
-3
CAG
23
-4
CFG
61
-2
BAX
47
-3
TXN
40
-3
EL
50
2
TSCO
66
-2
EQIX
54
-3
PYPL
29
-4
VFC
47
3
VRSN
49
-4
FDX
47
-4
O
31
-8
EQT
42
3
EQR
44
-7
OMC
51
-4
FMC
41
-3
PH
60
-2
TDC
38
-4
VIX
40
-9
DAL
54
-3
Financhill
Back

Palo Alto Networks Vs. Nektar Therapeutics Industry Stock Comparison

Sell
41

PANW
Palo Alto Networks

Last Price:
$173.18
Seasonality Move:
3.21%
Sell
43

NKTR
Nektar Therapeutics

Last Price:
$22.17
Seasonality Move:
-1.81%
Sell
41
Palo Alto Networks (PANW) is a Sell

Is Palo Alto Networks a Buy, Sell or Hold?

  • The current Palo Alto Networks [PANW] share price is $183.03. The Score for PANW is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • PANW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $22.07. The Score for NKTR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PANW Stock Price Chart

What is Palo Alto Networks's stock price today?

  • The Palo Alto Networks share price today is $183.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PANW is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $22.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

PANW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 26.54 Buy
Relative Strength Index (14 RSI): 36.5 Sell
Chaikin Money Flow: 14947395 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (192.16 - 203.72) Sell
Bollinger Bands (100): (174.7 - 199.72) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.17 Buy
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: -379983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.18 - 26.54) Sell
Bollinger Bands (100): (7.68 - 20.7) Buy

PANW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 197.7 Sell
20-day SMA: 196.95 Sell
50-day SMA: 196.25 Sell
200-day SMA: 188.19 Sell
8-day EMA: 74.18 Buy
20-day EMA: 34.13 Buy
50-day EMA: 14.48 Buy
200-day EMA: 3.73 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.06 Sell
20-day SMA: 24.32 Sell
50-day SMA: 17.69 Buy
200-day SMA: 14.91 Buy
8-day EMA: 8.86 Buy
20-day EMA: 4.08 Buy
50-day EMA: 1.73 Buy
200-day EMA: 0.45 Buy

Palo Alto Networks Earnings Growth & PANW Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.05 per share, an increase this year of $0.49 per share, and an increase next year of $0.41 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.

Palo Alto Networks Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):